A case of gangliocytic paraganglioma in the ampulla of Vater
Duodenal gangliocytic paraganglioma is an extremely rare tumor and few cases have been reported to date.
The authors report a case of gangliocytic paraganglioma verified by post-op pathology after pancreaticoduodenectomy for a tumor in the ampulla of Vater. The 56-year-old male patient concerned visited our emergency room with melena that started one week prior to hospitalization. The patient was diagnosed to have a tumor in the ampulla of Vater with bleeding on its surface. However post-op, he was diagnosed as having gangliocytic paraganglioma by immunohistochemistry.
This tumor has precise clinical implications, and if continuous follow up is conducted after careful diagnosis and surgical treatment, invasive major operations, such as, radical pancreaticoduodenectomy can be avoided.
KeywordsCarcinoid Tumor Choledochal Cyst Neuroendocrine Carcinoma Pancreatic Polypeptide Submucosal Tumor
Gangliocytic paragangliomas are rare tumors which are usually encountered in the second portion of the duodenum. They can be diagnosed histologically by the presence of epithelioid, spindle, and ganglion cells, which is similar to that observed for paraganglioma . Although gancliocytic paragangliomas have no specific accompanying symptoms, they are sometimes found due to bleeding caused by mucosal ulceration, and rarely because of huge mass effect, such as, abdominal pain or obstruction. However, they are usually detected incidentally during radiologic imaging conducted for different purposes . Here, we report a gangliocytic paraganglioma in the second portion of the duodenum in a patient hospitalized for melena, which was removed by pancreaticoduodenectomy. We also include a review of the literature.
Gangliocytic paraganglioma is a rare benign tumor of the digestive tract. Although some have reported cases of gangliocytic paraganglioma invading the proximal jejunum, about 90% are found in the second part of the duodenum, from where the tumor can invade the ampulla of Vater. In the WHO classification of tumors of digestive tract (2000), gangliocytic paraganglioma was independently classified as a type of epithelial tumor. Other duodenal neuroendocrine tumors, except for non-differentiated neuroendocrine carcinoma, were classified as carcinoid tumors. Males are affected slightly more commonly than females (1 to 1.8/1) and in terms of age at onset although the fifties are preferred, it has been encountered over an age range from 23 to 83 years. The endoscopic features of gangliocytic paraganglioma do not differ from those of other submucosal tumors. However, its preoperative pathologic diagnosis is difficult based on endoscopic biopsy alone, because of its submucosal nature, and therefore, endoscopy must be assisted by radioscopy. Gangliocytic paraganglioma is well defined by ultrasonography and is visualized as an isoechoic mass, whereas abdominal computer tomography visualizes it as mass-like soft tissue that is homogenously iso-attenuated, as is observed in muscles beside the vertebrae . Pancreatic head cancer in the duodenum, duodenal cancer, duodenal sarcoma, angioma, choledochal cyst, lipoma, hamartoma, and lymphoma must be differentiated from gangliocytic paraganglioma by radiography. This differentiation can be performed based on lesion's location, degree of attenuation by abdominal computer tomography, CBD dilatation, and enhancing pattern . However, accurate preoperative diagnosis is often difficult, due to the lack of histological confirmation. Although gangliocytic paraganglioma is incidentally found by radiological examinations and is asymptomatic in most cases, symptoms when present may be location dependent. According to a review of 51 cases reported in the literature by Burke et al , the reported symptoms were; abdominal pain in 13 cases, gastrointestinal bleeding in 6, melena in 6, anemia in 5, pyloric obstruction in one, and bile duct obstruction in one. Gangliocytic paraganglioma is histologically composed of three cell types, namely, epithelioid, ganglion, and spindle cells. However, the compositions of these cells vary . Nevertheless, gangliocytic paraganglioma is verifiable by immunohistochemical examination. In the described case, the patient was positive for synaptophysin and neuron specific antigen, focally positive for chromogranin, partially positive in stroma for S-100, and negative for cytokeratin. Several authors have reported that epithelioid and ganglion cells are positive to neuroendocrine peptides, such as, somatostatin, pancreatic polypeptide, and serotonin. Furthermore, it has been argued that epithelioid cells have the same origin as ganglion cells and that they are related to islet cell tumors , or alternatively, that carcinoid tumors of the duodenum have the proliferative growth pattern or harmatoma-like growth characteristics of carcinoid tumors . Gangliocytic paragangliomas follow a benign course and invasive growth patterns and lymph node metastasis are rare even for large tumors . Furthermore, in few cases with regional lymph node metastasis distant metastasis was not observed [5, 12]. Though lymph node metastasis usually only involves the transfer of epithelioid cells , in one case report all three cell types were transferred . Furthermore, although recurrence is generally considered not to occur, there are rare reports of gangliocytic paraganglioma recurrence [13, 14]. Tumors of the duodenum often require pancreaticoduodenectomy or lymph node dissection. However, because metastasis and the recurrence of gangliocytic paraganglioma is rare, and moreover no case of death resulting from this tumor has been reported, mass excision is considered sufficient to treat as long as abnormal features are not found in lymph nodes, and bile and pancreatic ducts by endoscopic ultrasonography. As was performed in our case, radical excision including pancreaticoduodenectomy has usually been performed, although reports are emerging regarding endoscopic resection . However, because the possibilities of recurrence and metastasis cannot be completely excluded, decisions on treatment methods must be made after careful preoperative staging of the disease prior to local treatment . Furthermore, continuous follow up at the out-patient department for early detecting of recurrence is deemed necessary.
Here we report a case of gangliocytic paraganglioma in the ampulla of vater. Although gangliocytic paraganglioma in the duodenum is an extremely rare disease, it shows a good prognosis as compared with other peri-ampulla of Vater tumors. Furthermore, if continuous follow up observation is conducted after obtaining a careful diagnosis, it can be treated only limited surgery like local excision, without performing pancreaticoduodenectomy or lymph node dissection.
Written informed consent was obtained from patient for reporting of this case, the copy of consent is available with editor in chief.
- 3.Yoo CY, Jung CK, Song KY, Kim SW, Lee KY: Gangliocytic Paraganglioma of the Duodenum. J Korean Surg Soc. 2007, 73: 68-71.Google Scholar
- 4.Stanley RH, Lauri AA: WHO Classification of Tumors: Pathology and Genetics of Tumors of Digestive System. 2000, Lyon: IARC press, 1Google Scholar
- 9.Nagai T, Torishima R, Nakashima H, Tanahashi J, Iwata M, Ookawara H, Yokoyama S, Yada K, Sato R, Murakami K, Fujioka T: Duodenal gangliocytic paraganglioma treated with endoscopic hemostasis and resection. J Gastroenterol. 2004, 39: 277-283. 10.1007/s00535-003-1289-2. doi: 10.1007/s00535-003-1289-2CrossRefPubMedGoogle Scholar
- 13.Sundararajan V, Robinson-Smith TM, Lowy AM: Duodenal gangliocytic paraganglioma with lymph node metastasis: a case report and review of the literature. Arch Pathol Lab Med. 2003, 127: 139-41.Google Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.